- Article
- Published:
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Naturevolume 304, pages596–602 (1983)Cite this article
4694Accesses
2851Citations
51Altmetric
Abstract
Transfection of embryo fibroblasts by a humanras oncogene does not convert them into tumour cells unless the fibroblasts are established and immortalized before transfection. The embryo fibroblasts become tumorigenic if a second oncogene such as a viral or cellularmyc gene or the gene for the polyoma large-T antigen is introduced together with theras gene.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others

Human cell transformation by combined lineage conversion and oncogene expression
References
Cairns, J.Nature255, 197–200 (1975).
Vogt, M. & Dulbecco, R.Proc. natn. Acad. Sci. U.S.A.49, 171–179 (1963).
Berenblum, I. & Shubik, P.Br. J. Cancer1, 388 (1947).
Emmelot, P. & Scherer, E.Cancer Res.37, 1702–1708 (1977).
Crawford, B. D., Barrett, J. C. & Ts'o, P. O. P.Molec. cell. Biol.3, 931–945 (1983).
Rassoulzadegan, M.et al.Nature300, 713–718 (1982).
Houweling, A., van den Elsen, P. J. & van der Eb, A. J.Virology105, 537–550 (1980).
van den Elsen, P. J., de Pater, S., Houweling, A., van der Veer, J. & van der Eb, A.Gene18, 175–185 (1982).
Hayward, W. S., Neel, B. G. & Astrin, S. M.Nature290, 475–80 (1981).
Payne, G. S., Bishop, J. M. & Varmus, H. E.Nature295, 209–214 (1982).
Cooper, G. M. & Neiman, P. E.Nature292, 857–858 (1981).
Murray, M. J.et al.Cell (in the press).
Murray, M. J., Shilo, B.-Z., Shih, C. & Weinberg, R. A.Cell25, 355–361 (1981).
Smotkin, D., Gianni, A. M., Rozenblatt, S. & Weinberg, R. A.Proc. natn. Acad. Sci. U.S.A.72, 4910–4913 (1975).
Aaronson, S. A. & Todaro, G. J.J. Cell Biol.72, 141–148 (1968).
Shih, C. & Weinberg, R. A.Cell29, 161–169 (1982).
Der, C. J., Krontiris, T. G. & Cooper, G. M.Proc. natn. Acad. Sci. U.S.A.79, 3637–3640 (1982).
Parada, L. F., Tabin, C. J., Shih, C. & Weinberg, R. A.Nature297, 474–479 (1982).
Santos, E., Tronick, S., Aaronson, S. A., Pulciani, S. & Barbacid, M.Nature298, 343–347 (1982).
Shih, T. Y., Weeks, M O., Young, H. A. & Scolnick, E. M.Virology96, 64–79 (1979).
Tabin, C. J.et al.Nature300, 143–149 (1982).
Perucho, M., Hanahan, D. & Wigler, M.Cell22, 309–317 (1980).
Pulciani, S.et al.Nature300, 539–542 (1982).
Hall, A., Marshall, C. J., Spurr, N. K. & Weiss, R. A.Nature303, 396–400 (1983).
Shimizu, K., Goldfarb, M., Perucho, M. & Wigler, M.Proc. natn. Acad. Sci. U.S.A.80, 383–387 (1983).
Graham, F. L. & van der Eb, A. J.Virology52, 456–467 (1973).
Mulligan, R. C. & Berg, P.Proc. natn. Acad. Sci. U.S.A.78, 2072–2076 (1981).
Perucho, M., Hanahan, D. & Wigler, M.Cell22, 309–317 (1980).
Freeman, A. E.et al.Proc. natn. Acad. Sci. U.S.A.70, 2415–2419 (1973).
Vennstrom, B., Moscovici, C., Goodman, H. M. & Bishop, J. M.J. Virol.39, 625–631 (1981).
Watson, D. K., Reddy, E. P., Duesberg, P. H. & Papas, T. S.Proc. natn. Acad. Sci. U.S.A.80, 2146–2150 (1983).
Alitalo, K.et al.Proc. natn. Acad. Sci. U.S.A.80, 100–104 (1983).
Colby, W. W., Chen, E. Y., Smith, D. H. & Levinson, A. D.Nature301, 722–725 (1983).
Laimins, L. A., Khoury, G., Gorman, C., Howard, B. & Gruss, P.Proc. natn. Acad. Sci. U.S.A.79, 6453–6457 (1982).
Shen-Ong, G. L. C., Keath, E. J., Piccoli, S. P. & Cole, M. D.Cell31, 443–452 (1982).
Treisman, R., Novak, U., Favaloro, J. & Kamen, R.Nature292, 595–600 (1981).
Tyndall, C., LaMantia, G., Thacker, C. M., Favaloro, J. & Kamen, R.Nucleic Acids Res.9, 6231–6250 (1981).
Taparowsky, E.et al.Nature300, 762–765 (1982).
Tsuchida, N., Ryder, T. & Ohtsubo, E.Science217, 937–939 (1982).
Dhar, R.et al.Science217, 934–937 (1982).
Beard, J. W. inViral Oncology (ed. Klein, G.) 55–88 (Raven, New York, 1980).
Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. & Cory, S.Proc. natn. Acad. Sci. U.S.A. (in the press).
Collins, S. J. & Groudine, M.Nature298, 679–681 (1982).
Dalla Favera, R., Wong-Staal, F. & Gallo, R. C.Nature299, 61–63 (1982).
Dalla Favera, R.,et al.Proc. natn. Acad. Sci. U.S.A.79, 7824–7827 (1982).
Taub, R.et al.Proc. natn. Acad. Sci. U.S.A.79, 7837–7841 (1982).
Crews, S., Barth, J., Hood, L., Prehn, J. & Calame, K.Science218, 1319–1321 (1982).
Marcu, R. B.et al.Proc. natn. Acad. Sci. U.S.A.80, 519–523 (1983).
Alitalo, K., Schwab, M., Lin, C. C., Varmus, H. E. & Bishop, J. M.Proc. natn. Acad. Sci. U.S.A.80, 1707–1711 (1983).
Gross, L.Oncogenic viruses, 931 (Pergamon, Oxford, 1970).
Quade, K.Virology98, 461–465 (1979).
Copeland, N. G. & Cooper, G. M.J. Virol.33, 1199–1202 (1980).
Willingham, M. C., Pastan, I., Shih, T. Y. & Scolnick, E. M.Cell19, 1005–1014 (1981).
Ito, Y.Virology98, 261–266 (1979).
Schaffhausen, B. S., Dorai, J., Arakere, G. & Benjamin, T. L.Molec. cell. Biol.2, 1187–1198 (1982).
Donner, P., Greiser-Wilke, I. & Moelling, K.Nature296, 262–266 (1982).
Abrams, H. D., Rohrschneider, L. R. & Eisenman, R. N.Cell29, 427–439 (1982).
Ito, Y., Spurr, N. & Dulbecco, R.Proc. natn. Acad. Sci. U.S.A.74, 1259–1263 (1977).
Feldman, L. T. & Nevins, J. R.Molec. cell. Biol.3, 829–838 (1983).
Pollack, R., Risser, R., Coulon, S. & Rifkin, D.Proc. natn. Acad. Sci. U.S.A.71, 4792–4796 (1974).
Andersson, P., Goldfarb, M. P. & Weinberg, R. A.Cell16, 63–75 (1979).
Ruley, H. E.Nature304, 602–606 (1983).
Author information
Authors and Affiliations
Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, and Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, 02139, USA
Hartmut Land, Luis F. Parada & Robert A. Weinberg
- Hartmut Land
You can also search for this author inPubMed Google Scholar
- Luis F. Parada
You can also search for this author inPubMed Google Scholar
- Robert A. Weinberg
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Land, H., Parada, L. & Weinberg, R. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.Nature304, 596–602 (1983). https://doi.org/10.1038/304596a0
Received:
Accepted:
Issue Date:
This article is cited by
RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
- Vincent Oei
- Linda Shyue Huey Chuang
- Yoshiaki Ito
Communications Biology (2023)
Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma
- Russell Moser
- Kay E. Gurley
- Christopher J. Kemp
Oncogene (2022)
Cellular senescence in neuroblastoma
- Sofia Zanotti
- Bieke Decaesteker
- Frank Speleman
British Journal of Cancer (2022)
MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma
- Yuxiong Lu
- Qing Yang
- Bo Li
Cell Death & Disease (2021)
Human cell transformation by combined lineage conversion and oncogene expression
- Biswajyoti Sahu
- Päivi Pihlajamaa
- Jussi Taipale
Oncogene (2021)